X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (176) 176
rats (153) 153
male (129) 129
neurosciences (118) 118
index medicus (56) 56
disease models, animal (47) 47
article (45) 45
rats, sprague-dawley (45) 45
behavioral sciences (36) 36
stroke (35) 35
humans (33) 33
recovery of function (33) 33
parkinson's disease (31) 31
clinical neurology (29) 29
dopamine (27) 27
mice (26) 26
rat (26) 26
behavior (24) 24
rats, long-evans (24) 24
sensorimotor (24) 24
time factors (24) 24
neurons (23) 23
behavior, animal - drug effects (22) 22
behavior, animal - physiology (21) 21
brain (21) 21
motor activity - drug effects (21) 21
motor activity - physiology (21) 21
female (20) 20
plasticity (19) 19
analysis of variance (18) 18
dopamine - metabolism (18) 18
forelimb - physiology (18) 18
neurology (18) 18
recovery (18) 18
brain injuries - physiopathology (17) 17
forelimb - innervation (17) 17
rodents (17) 17
sensorimotor cortex (17) 17
oxidopamine (16) 16
traumatic brain injury (16) 16
adult-rats (15) 15
injury (15) 15
neocortical damage (15) 15
rats, wistar (15) 15
brain injuries - pathology (14) 14
dose-response relationship, drug (14) 14
neurogenesis (14) 14
research (14) 14
neuronal plasticity - physiology (13) 13
rats, inbred strains (13) 13
analysis (12) 12
behavior, animal (12) 12
forelimb - physiopathology (12) 12
functional recovery (12) 12
parkinson disease - physiopathology (12) 12
parkinsons-disease (12) 12
recovery of function - physiology (12) 12
rehabilitation (12) 12
aging (11) 11
brain - pathology (11) 11
corpus striatum - drug effects (11) 11
erythropoietin (11) 11
models (11) 11
motor cortex (11) 11
pharmacology & pharmacy (11) 11
vocalization, animal - drug effects (11) 11
6-hydroxydopamine (10) 10
brain damage (10) 10
brain injuries - drug therapy (10) 10
brain-damage (10) 10
central-nervous-system (10) 10
cerebral ischemia (10) 10
exercise (10) 10
focal cerebral-ischemia (10) 10
mice, inbred c57bl (10) 10
neurons - drug effects (10) 10
neuroprotective agents - therapeutic use (10) 10
physiological aspects (10) 10
psychiatry (10) 10
somatosensory cortex - physiology (10) 10
spatial memory (10) 10
ultrasonic vocalization (10) 10
ultrasonics (10) 10
use-dependent exaggeration (10) 10
vibrissae - physiology (10) 10
6-ohda (9) 9
brain - drug effects (9) 9
ethanol (9) 9
ethanol - pharmacology (9) 9
hippocampus - drug effects (9) 9
hypothalamus - physiology (9) 9
in-vivo (9) 9
injuries (9) 9
nucleus-accumbens (9) 9
spatial learning (9) 9
treatment outcome (9) 9
animal-models (8) 8
cerebral cortex - pathology (8) 8
cocaine (8) 8
corpus striatum - metabolism (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Behavioural Brain Research, ISSN 0166-4328, 01/2005, Volume 156, Issue 2, pp. 201 - 213
The causes of nigrostriatal neuron degeneration in Parkinson's disease (PD) are not known, but it has been suggested that exogenous or endogenous factors or... 
Sinemet | Neuroprotection | Parkinson's disease | Methylphenidate | 6-Hydroxydopamine | methylphenidate | ORAL METHYLPHENIDATE | MPTP-TREATED MICE | FIBROBLAST-GROWTH-FACTOR | MONOAMINE TRANSPORTER VMAT2 | SUBSTANTIA-NIGRA | NEUROSCIENCES | INTRASTRIATAL 6-HYDROXYDOPAMINE | NUCLEUS-ACCUMBENS | NIGROSTRIATAL DOPAMINERGIC SYSTEM | 6-hydroxydopamine | NEUROTROPHIC FACTOR GDNF | neuroprotection | BEHAVIORAL SCIENCES | INCENTIVE-SENSITIZATION | Tyrosine 3-Monooxygenase - metabolism | Rotarod Performance Test - methods | Rats, Long-Evans | Motor Activity - drug effects | Male | Parkinson Disease - drug therapy | Oxidopamine | Substantia Nigra - cytology | Nerve Degeneration - chemically induced | Antiparkinson Agents - therapeutic use | Dose-Response Relationship, Drug | Carbidopa - therapeutic use | Drug Interactions | Levodopa - administration & dosage | Nerve Degeneration - prevention & control | Behavior, Animal - drug effects | Parkinson Disease, Secondary - prevention & control | Neurons - metabolism | Drug Therapy, Combination | Carbidopa - administration & dosage | Disease Models, Animal | Methylphenidate - administration & dosage | Movement - drug effects | Parkinson Disease - complications | Levodopa - therapeutic use | Rats | Immunohistochemistry - methods | Differential Threshold - drug effects | Animals | Cell Count - methods | Methylphenidate - therapeutic use | Antiparkinson Agents - administration & dosage | Nerve Degeneration - etiology | Drug Combinations | Parkinson Disease - etiology
Journal Article
Neuroscience, ISSN 0306-4522, 2009, Volume 163, Issue 3, pp. 877 - 889
Journal Article
Stroke, ISSN 0039-2499, 11/2004, Volume 35, Issue 11, pp. 2699 - 2701
Constraint-induced movement therapy improves outcome after chronic stroke, conforms experimental observations of neuronal plasticity, and proves the efficacy... 
Occupational therapy | Rehabilitation | Stroke, acute | Acute care | STROKE | rehabilitation | stroke, acute | PERIPHERAL VASCULAR DISEASE | MOTOR RECOVERY | MONKEYS | occupational therapy | CLINICAL NEUROLOGY | acute care | Animals | Humans | Physical Therapy Modalities | Stroke Rehabilitation | Motor Skills | Stroke - physiopathology | Recovery of Function
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2001, Volume 21, Issue 12, pp. 4427 - 4435
Rats with unilateral depletion of striatal dopamine (DA) show marked preferential use of the ipsilateral forelimb. Previous studies have shown that... 
Motor therapy | Dopamine | Movement | Parkinson's disease | Neurodegeneration | Plasticity | USE-DEPENDENT EXAGGERATION | COMPENSATORY ADJUSTMENTS | NEUROTROPHIC FACTOR | neurodegeneration | motor therapy | plasticity | SUBSTANTIA-NIGRA | NEUROSCIENCES | VESICULAR MONOAMINE TRANSPORTERS | UNILATERAL DOPAMINE DEPLETION | SENSORIMOTOR CORTEX LESIONS | MOTOR CORTEX | DENTATE GYRUS | movement | dopamine | PARKINSONS-DISEASE | Substantia Nigra - physiopathology | Oxidopamine - administration & dosage | Neural Pathways - drug effects | Vesicular Biogenic Amine Transport Proteins | Membrane Glycoproteins - metabolism | Forelimb - physiology | Rats, Long-Evans | Immobilization | Male | Neurons - cytology | Neuropeptides | Corpus Striatum - cytology | Medial Forebrain Bundle - drug effects | Apomorphine - pharmacology | Behavior, Animal - drug effects | Neurons - metabolism | Neural Pathways - physiopathology | Parkinson Disease, Secondary - chemically induced | Neurons - drug effects | Dopamine - metabolism | Disease Models, Animal | 3,4-Dihydroxyphenylacetic Acid - metabolism | Corpus Striatum - physiopathology | Microinjections | Vesicular Monoamine Transport Proteins | Rats | Body Temperature | Parkinson Disease - physiopathology | Parkinson Disease - prevention & control | Substantia Nigra - drug effects | Animals | Homovanillic Acid - metabolism | Membrane Transport Proteins | Corpus Striatum - drug effects | Casts, Surgical
Journal Article
Journal of Neural Transmission, ISSN 0300-9564, 07/2009, Volume 116, Issue 7, pp. 791 - 806
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, simvastatin, is used for lowering elevated low-density lipoprotein cholesterol concentrations.... 
Neurodegenerative disease | Mitochondria | Sensorimotor assessment | Statins | Proteomics | Rotenone | UBIQUITIN-PROTEASOME SYSTEM | CREUTZFELDT-JAKOB DISEASE | ALPHA-SYNUCLEIN PROTEINS | NEUROSCIENCES | INTERMEDIATE-FILAMENT PROTEIN | CLINICAL NEUROLOGY | HEAT-SHOCK PROTEINS | DENSITY-LIPOPROTEIN CHOLESTEROL | TRAUMATIC BRAIN-INJURY | PHOSPHATIDYLETHANOLAMINE-BINDING-PROTEIN | CENTRAL-NERVOUS-SYSTEM | PARKINSONS-DISEASE | Substantia Nigra - physiopathology | Uncoupling Agents - pharmacology | Recovery of Function - drug effects | Oxidative Stress - physiology | Mitochondrial Diseases - metabolism | Proteome - drug effects | Male | Substantia Nigra - metabolism | Neurodegenerative Diseases - drug therapy | Simvastatin - pharmacology | Mitochondrial Proteins - drug effects | Neuroprotective Agents - pharmacology | Mitochondrial Proteins - metabolism | Mass Spectrometry | Rotenone - pharmacology | Free Radicals - metabolism | Recovery of Function - physiology | Proteomics - methods | Disease Models, Animal | Mitochondrial Diseases - drug therapy | Rats | Mitochondria - metabolism | Mitochondria - drug effects | Neurodegenerative Diseases - metabolism | Electron Transport Chain Complex Proteins - drug effects | Rats, Sprague-Dawley | Substantia Nigra - drug effects | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Neurodegenerative Diseases - physiopathology | Electron Transport Chain Complex Proteins - metabolism | Oxidative Stress - drug effects | Mitochondrial Diseases - physiopathology | Proteome - metabolism | Enzymes | Brain | Nervous system diseases | Thiols | Neurons | Low density lipoproteins | Simvastatin | Mitochondrial DNA | Machinery | Cholesterol | Antilipemic agents | Magneto-electric machines | Analysis | Physiological aspects | Models | Mass spectrometry | Injuries
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 2008, Volume 14, Issue 2, pp. S172 - S175
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 10/2011, Volume 34, Issue 7, pp. 1040 - 1052
The tumor suppressor protein p53 (Trp53) and the cell cycle inhibitor p27 Kip1 (Cdknb1) have both been implicated in regulating proliferation of adult... 
neurogenesis | sub‐ventricular zone | proliferation | stem cell | cell cycle | neurons | Sub-ventricular zone | Proliferation | Neurons | Neurogenesis | Stem cell | Cell cycle | sub-ventricular zone
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 08/1996, Volume 16, Issue 15, pp. 4776 - 4786
Journal Article
Behavioral Neuroscience, ISSN 0735-7044, 10/1999, Volume 113, Issue 5, pp. 914 - 924
Rats with kainate-colchicine hippocampal lesions (HL) and controls (C) were initially trained in the Morris water maze with procedures that deterred their... 
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1230, pp. 247 - 257
Journal Article